Prinoxodan
Prinoxodan (RGW2938) is a phosphodiesterase inhibitor.
Product Specifications
CAS Number
[111786-07-3]
Product Name Alternative
RGW2938
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/RGW2938.html
Purity
99.83
Solubility
Ethanol : < 1 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1NC2=C(C=C(C3=NNC(CC3)=O)C=C2)CN1C
Molecular Formula
C13H14N4O2
Molecular Weight
258.28
Precautions
H302, H315, H319, H335
References & Citations
[1]Artigou JY, et al. [Evaluation of a new cardiotonic agent on human isolated atrium]. Ann Cardiol Angeiol (Paris) . 1993 Feb;42 (2) :79-82.|[2]Barrett JA, et al. Pharmacology of RG W-2938: a cardiotonic agent with vasodilator activity. J Cardiovasc Pharmacol. 1990 Oct;16 (4) :537-45.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
C2615-20F 100 µg
CENPF (Centromere Protein F, CENP-F, AH Antigen, Kinetochore Protein CENPF, Mitosin)
Ask
View Details 